These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 15752936

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Possible role of BNP for an early diagnosis of asymptomatic left ventricular dysfunction: a retrospective study.
    De Vecchis R, Esposito C, Ariano C, Di Biase G.
    Minerva Cardioangiol; 2014 Apr; 62(2):147-59. PubMed ID: 24686994
    [Abstract] [Full Text] [Related]

  • 9. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S, Necozione S, Guarracini L, Fratini S, Cisternino P, di Orio F, Penco M.
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [Abstract] [Full Text] [Related]

  • 10. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
    de Lemos JA, McGuire DK, Khera A, Das SR, Murphy SA, Omland T, Drazner MH.
    Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. B-type natriuretic peptide level in the diagnosis of asymptomatic diastolic dysfunction.
    Karaca I, Gülcü E, Yavuzkir M, Dağli N, Ilkay E, Ozbay Y, Işik A, Arslan N.
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):262-7. PubMed ID: 17785213
    [Abstract] [Full Text] [Related]

  • 14. Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue Doppler imaging parameters and NT-pro-BNP levels for adverse outcome.
    Ikonomidis I, Nikolaou M, Dimopoulou I, Paraskevaidis I, Lekakis J, Mavrou I, Tzanela M, Kopterides P, Tsangaris I, Armaganidis A, Kremastinos DT.
    Shock; 2010 Feb; 33(2):141-8. PubMed ID: 19487972
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients.
    Wei T, Zeng C, Chen L, Chen Q, Zhao R, Lu G, Lu C, Wang L.
    Eur J Heart Fail; 2005 Jan; 7(1):75-9. PubMed ID: 15642535
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Natriuretic peptides as indicators of cardiac remodeling in hypertensive patients.
    Magnusson M, Jovinge S, Rydberg E, Dahlöf B, Hall C, Nielsen OW, Grubb A, Willenheimer R.
    Blood Press; 2009 Jan; 18(4):196-203. PubMed ID: 19562575
    [Abstract] [Full Text] [Related]

  • 19. Direct comparison of B-type natriuretic peptide and N-terminal pro-BNP for assessment of cardiac function in a large population of symptomatic patients.
    Park HJ, Baek SH, Jang SW, Kim DB, Shin DI, Shin WS, Kim PJ, Jung HB, Jung HO, Seung KB, Choi KB.
    Int J Cardiol; 2010 Apr 30; 140(3):336-43. PubMed ID: 19147239
    [Abstract] [Full Text] [Related]

  • 20. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.
    J Heart Lung Transplant; 2007 May 30; 26(5):516-21. PubMed ID: 17449423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.